BRIEF-European Commission approves MSD's Keytruda for treatment of melanoma in adults
July 22, 2015 at 07:05 AM EDT
* European commission has approved keytruda (pembrolizumab), company`s anti-pd-1 therapy, for treatment of advanced (unresectable or metastatic) melanoma in adults
